##  [Shareholder information](/investors/shareholder-information "Shareholder information") 

  [ 

 

###  General Meetings 

Find information about our General Meetings.

 

 

 ](/investors/shareholder-information/general-meetings) [ 

 

###  American Depository Receipts (ADR) 

Find information for holders of Novartis American Depository Receipts.

 

 

 ](/investors/shareholder-information/american-depositary-receipts-adr) 





 [ 

 

###  Share buyback 

Find information about the Novartis share buyback program.

 

 

 ](/investors/shareholder-information/share-buy-back) [ 

 

###  Frequently asked questions 

Review key questions and answers about Novartis shares, ADRs, general finance, ESG and investor relations services.

 

 

 ](/investors/shareholder-information/frequently-asked-questions) 





 

 

 



 ![Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida](/sites/novartis_com/files/styles/cta_image/public/2025-01/portrait-of-kate-kostelyk-and-her-labrador.jpg.webp?itok=4HIqaVLd "Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida") 

 

##  Reporting and transparency hub 

Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.



 

 [Learn more](/investors/reporting-and-transparency-hub "Learn more")